This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.

Released: July 12, 2026·Last reviewed: October 15, 2026·Prices re-read October 15, 2026 (rows marked)·Methodology v4.1

Researched By

Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

Shed review (2026): pricing, programs, pros & limitations

Verdict

The widest range of formats in the category: injections, sublingual drops, lozenges and oral tablets. Microdose semaglutide from $149 and microdose tirzepatide $199; injectable semaglutide $199 / $179 / $159 and tirzepatide $299 / $269 / $239 on 1-, 6- and 12-month plans (read October 15, 2026). Brand-name products require a separate $125/mo membership. 2-month minimum on everything. This review reflects figures marked reported — pending verification as of August 4, 2026; where a figure is provider-reported we say so rather than presenting it as independently confirmed.

What does this provider actually offer?

Shed snapshot — verification status per field, July 12, 2026
Field	Detail	Status
Starting price	$149/mo semaglutide microdose; $239 tirzepatide (12-month), read Oct 15	Re-read Oct 15 · changed
Renewal price	$299 tirzepatide month to month; $199 semaglutide	Reported — pending verification
Highest-dose price	Dose pricing not stated on its Oct 15 pages	Reported — pending verification
Membership fee	$125/mo for brand-name	Reported — pending verification
Labs	Pending research	Reported — pending verification
Shipping	Included	Reported — pending verification
Commitment	2-month minimum	Reported — pending verification
Pharmacy	Not independently verified	Reported — pending verification
Clinician	Clinical support	Reported — pending verification
States served	Pending research	Reported — pending verification

What does it actually cost at a maintenance dose?

The widest range of formats in the category: injections, sublingual drops, lozenges and oral tablets. Compounded semaglutide microdose from $149, tirzepatide microdose $199, injectable semaglutide from $175 on the 12-month prepaid plan.

Limitation: Its October 15 pages no longer say the price rises with dose. Brand-name products require a separate $125/mo membership. 2-month minimum on everything.

Who prescribes it, and what does the clinical review involve?

A legitimate GLP-1 program requires a licensed clinician to review the patient's history before any prescription. Clinical support. Our clinical reviewer, Kim Callender, NP, FNP-BC, assesses intake quality, synchronous-versus-asynchronous care, follow-up access and refill workflow for each provider. Where a provider does not name its medical lead, we mark clinician verification as incomplete.

Which pharmacy fills it, and where does the medication come from?

Pharmacy transparency is one of the strongest legitimacy signals. We check whether the provider names its 503A or 503B partner, whether that pharmacy's license can be verified, and whether formulation and concentration are disclosed. For Shed: Not independently verified.

Compounding status — read before enrollingCompounded drugs are not FDA-approved: the agency does not review them for safety, effectiveness or quality before they are marketed. Federal law also bars compounding drugs that are essentially a copy of a commercially available approved product — a bar that is lifted only while the drug is on the FDA shortage list. Both shortages are over. The FDA declared the tirzepatide shortage resolved on October 2, 2024 and the semaglutide shortage resolved on February 21, 2025, and enforcement discretion ended for all compounders between February 18 and May 22, 2025. On April 30, 2026 the FDA went further, proposing to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list on a finding of no clinical need. Routine compounding of these molecules is therefore no longer lawful on the basis that made the market — a fact most comparison sites still describe as "permanent legitimacy." It is not. The comment period on the 503B proposal closed July 30, 2026, and no final decision had been published as of October 15, 2026. On September 18, 2026 FDA told Empower Pharmacy that compounded tirzepatide and semaglutide products it examined “appear to be essentially copies” of approved drugs (warning letter 738238).

Where does it hold up, and where does it fall short?

Advantages

Shed: The widest range of formats in the category: injections, sublingual drops, lozenges…
Pricing structure is disclosed clearly enough to evaluate
Clinician oversight is stated

Limitations

Its October 15 pages no longer say the price rises with dose. Brand-name products require a separate $125/mo membership. 2-month minimum on everything.
Pharmacy partner not independently verified by us yet

What did we verify, and what could we not?

Every material claim on this page traces to a source, a capture date and a verification status.

Evidence ledger — claim, source, date checked, status
Claim	Source	Checked	Status
Starting price	Provider plan documentation	July 12, 2026	Reported — pending verification
Pharmacy partner	Provider disclosure	July 12, 2026	Reported — pending verification
Clinician / medical lead	Provider disclosure	July 12, 2026	Reported — pending verification
Shipping terms	Provider terms page	July 12, 2026	Reported — pending verification
State availability	Provider disclosure	July 12, 2026	Evaluation in progress

What else should you compare it against?

Compare Shed against NexLife · Found · Oak Longevity. For the full field, see best GLP-1 programs and most affordable compounded tirzepatide.

What did the provider say when we asked?

Shed may submit factual corrections through our corrections process. Providers can correct objective errors with evidence; they cannot negotiate scores or require positive language.

Frequently asked questions

Is Shed legitimate?

Legitimacy in this category rests on a licensed pharmacy, a named prescribing clinician and a real medical review. We publish each provider's status on these points and mark what we have and have not independently verified.

How much does Shed cost?

$149/mo semaglutide microdose; $239 tirzepatide (12-month), read Oct 15 to start (reported — pending verification). See the pricing section for renewal and highest-dose figures.

Does Shed require a prescription?

Yes. Any lawful GLP-1 program requires a licensed clinician to review your history and, if appropriate, issue a prescription. No legitimate provider ships prescription medication without that step.

Sources

Provider website, terms, pricing and pharmacy-disclosure pages (captured July 12, 2026).
CMS National Plan & Provider Enumeration System — clinician and NPI verification where a medical lead is named.
U.S. Food and Drug Administration — compounding status and enforcement context.
Our published scoring methodology, version 4.1.

Spotted an error? Submit a correction.

How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.